Viking Therapeutics
VKTX
#2266
Rank
โ‚ฌ6.40 B
Marketcap
52,17ย โ‚ฌ
Share price
-9.14%
Change (1 day)
462.24%
Change (1 year)

Viking Therapeutics (VKTX) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚ฌ25.05 Million

According to Viking Therapeutics 's latest financial reports the company's total liabilities are โ‚ฌ25.05 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Viking Therapeutics - Total liabilities on balance sheet (from 2014 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚ฌ18.15 M-16.08%
2022-12-31โ‚ฌ21.63 M179.12%
2021-12-31โ‚ฌ7.75 M-21.59%
2020-12-31โ‚ฌ9.88 M55.15%
2019-12-31โ‚ฌ6.37 M59.76%
2018-12-31โ‚ฌ3.98 M-44.73%
2017-12-31โ‚ฌ7.21 M16.88%
2016-12-31โ‚ฌ6.17 M0.52%
2015-12-31โ‚ฌ6.14 M-70.33%
2014-12-31โ‚ฌ20.69 M6531.71%
2013-12-31โ‚ฌ0.31 M291.62%
2012-12-31โ‚ฌ0.07 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚ฌ1.12 B 4,385.70%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.82 B 3,211.51%๐Ÿ‡บ๐Ÿ‡ธ USA